Lilly CEO says appropriate assessment of both benefits and risks critical in regulatory process
2 November 2011 | By Eli Lilly and Company
John Lechleiter calls for balanced decision-making...
List view / Grid view
2 November 2011 | By Eli Lilly and Company
John Lechleiter calls for balanced decision-making...
19 October 2011 | By Eli Lilly and Company
FDA has approved a new use for BYETTA® (exenatide) injection....
7 October 2011 | By Eli Lilly and Company
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil) tablets for once daily use for the treatment of men who have both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia (ED+BPH). The FDA also approved Cialis…
26 September 2011 | By Eli Lilly and Company
New data from PARAMOUNT study shows benefit in this hard-to-treat population...
26 September 2011 | By Eli Lilly and Company
CHMP has issued a positive opinion for the use of ALIMTA® as continuation maintenance therapy for deadly form of lung cancer...
20 September 2011 | By Eli Lilly and Company
Observational study leads to systemic approach to improve minority enrollment...
12 September 2011 | By Eli Lilly and Company
Results presented at EASD 2011...
25 August 2011 | By Eli Lilly and Company, Boehringer Ingelheim
Linagliptin is the only DPP-4 inhibitor to be approved at one dosage strength for adults with type 2 diabetes in Europe, without any need for dose adjustments...
25 August 2011 | By Boehringer Ingelheim
Marketing Authorisation from the European Commission for Trajenta® (linagliptin)...
9 August 2011 | By Eli Lilly and Company
Eli Lilly and Company announced that data on EVISTA® (raloxifene HCl tablets) therapy for more than three years was published...
19 July 2011 | By Eli Lilly and Company
Data presented from the first of two Phase III trials of semagacestat...
18 July 2011 | By Eli Lilly and Company
Winner of the 2011 de Leon Prize in Neuroimaging...
18 July 2011 | By Eli Lilly and Company
New study results released...
11 July 2011 | By Eli Lilly and Company
Biopharmaceuticals be included in transatlantic trade and economic discussions...
1 July 2011 | By Eli Lilly and Company
Fionnuala Walsh, Ph.D., will join the executive committee of Eli Lilly and Company on July 1...